Aldosterone Antagonism With Eplerenone Does Not Adversely Affect Plasma Glucose Levels in Patients With Diabetes Mellitus: Findings From a Post Hoc Analysis of the EPHESUS Trial

Authors

Prakash Deedwania MDFollow
Bertram Pitt MDFollow
Ravi V. Desai MD, Lehigh Valley Health NetworkFollow
Marjan Mujib MD, MPHFollow
Inmaculada B. Aban PhDFollow
John Vincent
Eva Turgonyi
Ali Ahmed MD, MPHFollow

Publication/Presentation Date

8-30-2010

Comments

European Heart Journal ( 2010 ) 31 ( Abstract Supplement ), 423-424

Published In/Presented At

Deedwania, P., Pitt, B., Desai, R., Mujib, M., Aban, I., Vincent, J., Turgonyi, E., & Ahmed, A. (2010, August 28-September 1). Aldosterone antagonism with eplerenone does not adversely affect plasma glucose levels in patients with diabetes mellitus: Findings from a post hoc analysis of the EPHESUS trial. Poster presented at: The 2010 European Society of Cardiology Congress, Stockholm, Sweden.

Disciplines

Cardiology | Chemicals and Drugs | Endocrinology, Diabetes, and Metabolism | Medical Specialties | Medicine and Health Sciences

Department(s)

Department of Medicine, Cardiology Division

Document Type

Poster